Sarepta Therapeutics (SRPT) Amortizatization of Intangibles (2014 - 2026)

Sarepta Therapeutics (SRPT) recorded quarterly Amortizatization of Intangibles of -$530000.0 in Q1 2026, down 39.47% quarter-over-quarter from -$380000.0 in Q4 2025, and up 72.28% on a YoY basis from -$307638.1 in Q1 2025.

Sarepta Therapeutics (SRPT) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

Sarepta Therapeutics' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at -$530000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles rose 72.28% year-over-year to -$530000.0; the TTM figure through Mar 2026 stood at -$3.9 million (up 86.88% YoY), while the FY2025 annual figure was -$5.3 million, up 86.86% from the prior year.
  • Amortizatization of Intangibles was -$530000.0 for Q1 2026 at Sarepta Therapeutics, down from -$380000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$50000.0 in Q1 2022 to a low of -$13.3 million in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged -$6.1 million across 5 years, with a median of -$6.1 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles tumbled 17202.0% in 2023, then jumped 94.41% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$6.1 million in 2022, then slumped by 117.33% to -$13.3 million in 2023, then jumped by 48.96% to -$6.8 million in 2024, then surged by 94.41% to -$380000.0 in 2025, then slumped by 39.47% to -$530000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at -$530000.0 (Q1 2026), -$380000.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13,267.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Sarepta Therapeutics 1.61 Bn 923.39 Mn 291.52 Mn -530,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -530,000.00
Mar 31, 2026 -530,000.00
Dec 31, 2025 -380,000.00
Dec 31, 2025 -380,000.00
Sep 30, 2025 -1.13 Mn
Sep 30, 2025 -1.13 Mn
Jun 30, 2025 -1.87 Mn
Jun 30, 2025 -1.87 Mn
Mar 31, 2025 -1.91 Mn
Mar 31, 2025 -1.91 Mn
Dec 31, 2024 -6.80 Mn
Dec 31, 2024 -6.80 Mn
Sep 30, 2024 -10.62 Mn
Sep 30, 2024 -10.62 Mn
Jun 30, 2024 -10.46 Mn
Jun 30, 2024 -10.46 Mn
Mar 31, 2024 -12.40 Mn
Mar 31, 2024 -12.40 Mn
Dec 31, 2023 -13.33 Mn
Dec 31, 2023 -13.33 Mn